{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:08Z","timestamp":1792783148858,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["374011584\/3T"],"award-info":[{"award-number":["374011584\/3T"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft","id":[{"id":"https:\/\/ror.org\/043j0f473","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroinflammation is central to Alzheimer\u2019s disease (AD) pathogenesis, yet its contribution to region\u2010specific brain atrophy remains unclear. We examined whether cerebrospinal fluid (CSF) biomarkers predict longitudinal atrophy in the hippocampus and basal forebrain and mediate the impact of AD pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 227 DELCODE participants with baseline CSF measures and longitudinal structural MRI were analyzed. Four latent factors (synaptic, microglia, chemokine\/cytokine, complement) were derived to capture shared variance across biomarkers. Latent factors represent unobserved biological domains inferred from related CSF markers. In addition, four single biomarkers (neurogranin, sTREM2, YKL-40, ferritin) were tested separately. Regional atrophy rates were estimated using linear mixed-effects models including biomarker\u2009\u00d7\u2009time, A\/T classification, diagnosis, and covariates (age, sex, education, ApoE-\u03b54). Individual slopes were then entered into mediation models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Higher synaptic latent factor (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u2212\u00a00.019, pFDR\u2009=\u20090.021) and YKL-40 (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u2212\u00a00.020, pFDR\u2009=\u20090.025) significantly predicted hippocampal atrophy. Only these two markers remained significant after correction for multiple comparisons. Mediation analyses revealed significant indirect effects of the synaptic latent factor and YKL-40 on hippocampal atrophy across all A\/T groups. No biomarker was associated with basal forebrain atrophy (pFDR\u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Latent factors captured shared biological variance across related biomarkers and provided a more robust representation of underlying biological domains than single biomarkers. This approach identified synaptic dysfunction and astroglial activation as key links between AD pathology and hippocampal neurodegeneration. These findings highlight synaptic and glial pathways as promising targets for disease-modifying interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13564-5","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:47:52Z","timestamp":1766551672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CSF biomarkers of neuroinflammation are associated with regional atrophy"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3134-6580","authenticated-orcid":false,"given":"Serap","family":"\u00d6zl\u00fc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dyrba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Grazia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Brosseron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Buerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dechent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"D\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Fliessbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hellmann-Regen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Janowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kilimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kronm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Laske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"L\u00fcsebrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris-Stephan","family":"Rauchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayda","family":"Rostamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Sodenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Spottke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike Jakob","family":"Spruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"5","key":"13564_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH, Edison P, Ramirez A, Cruchaga C, Lambert JC, Laza AR, Sanchez-Mut JV, Fischer A, Castro-Gomez S, Stein TD, Kleineidam L, Riechers SP (2025) Neuroinflammation in Alzheimer disease. Nature Rev Immunol 25(5):321\u2013352","journal-title":"Nature Rev Immunol"},{"key":"13564_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhaf013","author":"R Gan","year":"2025","unstructured":"Gan R, Xie H, Zhao Z, Wu X, Wang R, Wu B, Chen Q, Jia Z (2025) Investigation of patterns and associations of neuroinflammation in cognitive impairment. Cereb Cortex. https:\/\/doi.org\/10.1093\/cercor\/bhaf013","journal-title":"Cereb Cortex"},{"issue":"4","key":"13564_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41380-023-02387-3","volume":"29","author":"D Hayek","year":"2024","unstructured":"Hayek D, Ziegler G, Kleineidam L, Brosseron F, Nemali A, Vockert N, Ravichandran KA, Betts MJ, Peters O, Schneider LS, Wang X, Priller J, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Bartels C, Rostamzadeh A, Glanz W, Buerger K, Maass A (2024) Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition. Mol Psychiatr. 29(4):992\u20131004. https:\/\/doi.org\/10.1038\/s41380-023-02387-3","journal-title":"Mol Psychiatr."},{"issue":"2","key":"13564_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","volume":"12","author":"YL Rao","year":"2022","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A (2022) Hippocampus and its involvement in Alzheimer\u2019s disease: a review. 3 Biotech 12(2):55. https:\/\/doi.org\/10.1007\/s13205-022-03123-4","journal-title":"3 Biotech"},{"issue":"10","key":"13564_CR5","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1002\/alz.14179","volume":"20","author":"JN Geigenm\u00fcller","year":"2024","unstructured":"Geigenm\u00fcller JN, Tari AR, Wisloff U, Walker TL (2024) The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer\u2019s disease. Alzheimers Dement 20(10):7369\u20137383. https:\/\/doi.org\/10.1002\/alz.14179","journal-title":"Alzheimers Dement"},{"issue":"6","key":"13564_CR6","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF (2022) Role of cholinergic signaling in Alzheimer\u2019s Disease. Molecules 27(6):1816. https:\/\/doi.org\/10.3390\/molecules27061816","journal-title":"Molecules"},{"key":"13564_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuroscience.2015.08.033","volume":"309","author":"R de Flores","year":"2015","unstructured":"de Flores R, La Joie R, Ch\u00e9telat G (2015) Structural imaging of hippocampal subfields in healthy aging and Alzheimer\u2019s disease. Neuroscience 309:29\u201350. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.08.033","journal-title":"Neuroscience"},{"issue":"10","key":"13564_CR8","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1007\/s00259-020-04752-8","volume":"47","author":"S Yan","year":"2020","unstructured":"Yan S, Zheng C, Cui B, Qi Z, Zhao Z, An Y, Qiao L, Han Y, Zhou Y, Lu J (2020) Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET\/MRI in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 47(10):2440\u20132452. https:\/\/doi.org\/10.1007\/s00259-020-04752-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"13564_CR9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s13760-023-02235-9","volume":"123","author":"H Qu","year":"2023","unstructured":"Qu H, Ge H, Wang L, Wang W, Hu C (2023) Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer\u2019s disease. Acta Neurol Belg 123(4):1381\u20131393. https:\/\/doi.org\/10.1007\/s13760-023-02235-9","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"13564_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159x13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer\u2019s disease: targeting the cholinergic system. Curr Neuropharmacol 14(1):101\u2013115. https:\/\/doi.org\/10.2174\/1570159x13666150716165726","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"13564_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/NEN.0b013e31816a1df3","volume":"67","author":"C Geula","year":"2008","unstructured":"Geula C, Nagykery N, Nicholas A, Wu CK (2008) Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol 67(4):309\u2013318. https:\/\/doi.org\/10.1097\/NEN.0b013e31816a1df3","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"13564_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s00259-016-3349-x","volume":"43","author":"R Roy","year":"2016","unstructured":"Roy R, Niccolini F, Pagano G, Politis M (2016) Cholinergic imaging in dementia spectrum disorders. Eur J Nucl Med Mol Imaging 43(7):1376\u20131386. https:\/\/doi.org\/10.1007\/s00259-016-3349-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"13564_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2023.09.002","volume":"132","author":"Y Xia","year":"2023","unstructured":"Xia Y, Maruff P, Dor\u00e9 V, Bourgeat P, Laws SM, Fowler C, Rainey-Smith SR, Martins RN, Villemagne VL, Rowe CC, Masters CL, Coulson EJ, Fripp J (2023) Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer\u2019s disease. Neurobiol Aging 132:120\u2013130. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.09.002","journal-title":"Neurobiol Aging"},{"issue":"12","key":"13564_CR14","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1111\/ejn.16361","volume":"59","author":"R Morais-Ribeiro","year":"2024","unstructured":"Morais-Ribeiro R, Almeida FC, Coelho A, Oliveira TG, Alzheimer\u2019s Disease Neuroimaging Initiative (2024) Differential atrophy along the longitudinal hippocampal axis in Alzheimer\u2019s disease. Eur J Neurosci 59(12):3376\u20133388. https:\/\/doi.org\/10.1111\/ejn.16361","journal-title":"Eur J Neurosci"},{"issue":"5","key":"13564_CR15","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1002\/alz.13780","volume":"20","author":"A Kapasi","year":"2024","unstructured":"Kapasi A, Yu L, Leurgans SE, Agrawal S, Boyle PA, Bennett DA, Schneider JA (2024) Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults. Alzheimers Dement 20(5):3193\u20133202. https:\/\/doi.org\/10.1002\/alz.13780","journal-title":"Alzheimers Dement"},{"issue":"10","key":"13564_CR16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging 27(10):1372\u20131384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.012","journal-title":"Neurobiol Aging"},{"issue":"10","key":"13564_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.15252\/emmm.201606540","volume":"8","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Insel PS, Palmqvist S, Portelius E, Zetterberg H, Weiner M, Blennow K, Hansson O, Alzheimer\u2019s Disease Neuroimaging Initiative (2016) Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer\u2019s disease. EMBO Mol Med 8(10):1184\u20131196. https:\/\/doi.org\/10.15252\/emmm.201606540","journal-title":"EMBO Mol Med"},{"issue":"1","key":"13564_CR18","doi-asserted-by":"publisher","first-page":"e12258","DOI":"10.1002\/dad2.12258","volume":"14","author":"U Morar","year":"2022","unstructured":"Morar U, Izquierdo W, Martin H, Forouzannezhad P, Zarafshan E, Unger E, Bursac Z, Cabrerizo M, Barreto A, Vaillancourt DE, DeKosky ST, Loewenstein D, Duara R, Adjouadi M (2022) A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non-converter Alzheimer\u2019s disease subjects with consideration for their amyloid beta status. Alzheimers Dement 14(1):e12258. https:\/\/doi.org\/10.1002\/dad2.12258","journal-title":"Alzheimers Dement"},{"issue":"7","key":"13564_CR19","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/brain\/awae032","volume":"147","author":"J Nilsson","year":"2024","unstructured":"Nilsson J, Pichet Binette A, Palmqvist S, Brum WS, Janelidze S, Ashton NJ, Spotorno N, Stomrud E, Gobom J, Zetterberg H, Brinkmalm A, Blennow K, Hansson O (2024) Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases. Brain 147(7):2414\u20132427. https:\/\/doi.org\/10.1093\/brain\/awae032","journal-title":"Brain"},{"issue":"6","key":"13564_CR20","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41380-025-02939-9","volume":"30","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H (2025) Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry 30(6):2783\u20132798. https:\/\/doi.org\/10.1038\/s41380-025-02939-9","journal-title":"Mol Psychiatry"},{"key":"13564_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-018-0127-7","volume":"7","author":"H Zhang","year":"2018","unstructured":"Zhang H, Ng KP, Therriault J, Kang MS, Pascoal TA, Rosa-Neto P, Gauthier S, Alzheimer\u2019s Disease Neuroimaging Initiative (2018) Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer\u2019s disease. Transl Neurodegener 7:23. https:\/\/doi.org\/10.1186\/s40035-018-0127-7","journal-title":"Transl Neurodegener"},{"issue":"9","key":"13564_CR22","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","volume":"91","author":"S Janelidze","year":"2018","unstructured":"Janelidze S, Mattsson N, Stomrud E, Lindberg O, Palmqvist S, Zetterberg H, Blennow K, Hansson O (2018) CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease. Neurology 91(9):e867\u2013e877. https:\/\/doi.org\/10.1212\/WNL.0000000000006082","journal-title":"Neurology"},{"issue":"1","key":"13564_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-020-00407-2","volume":"15","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Su\u00e1rez-Calvet M, Frontzkowski L, Moore A, Hohman TJ, Morenas-Rodriguez E, Nuscher B, Shaw L, Trojanowski JQ, Dichgans M, Kleinberger G, Haass C, Ewers M, Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) (2020) Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration. Mol Neurodegener 15(1):57. https:\/\/doi.org\/10.1186\/s13024-020-00407-2","journal-title":"Mol Neurodegener"},{"issue":"507","key":"13564_CR24","doi-asserted-by":"publisher","first-page":"eaav6221","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M, Trojanowski JQ, Shaw LM, Weiner MW, Haass C, Alzheimer\u2019s Disease Neuroimaging Initiative (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med 11(507):eaav6221. https:\/\/doi.org\/10.1126\/scitranslmed.aav6221","journal-title":"Sci Transl Med"},{"issue":"4","key":"13564_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Su\u00e1rez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, Hassenstab J, McDade E, Feederle R, Karch CM, Schlepckow K, Morris JC, Kleinberger G, Nellgard B, V\u00f6glein J, Blennow K, Zetterberg H, Ewers M, Jucker M, Levin J, Bateman RJ, Haass C, Adams S, Allegri R, Araki A, Barthelemy N, Bechara J, Berman S, Bodge C, Brandon S, Brooks W (Bill), Brosch J, Buck J, Buckles V, Carter K, Cash L, Chen C, Chhatwal J, Chrem P, Chua J, Chui H, Cruchaga C, Day GS, De La Cruz C, Denner D, Diffenbacher A, Dincer A, Donahue T, Douglas J, Duong D, Egido N, Esposito B, Farlow M, Feldman B, Fitzpatrick C, Flores S, Fox N, Franklin E, Friedrichsen N, Fujii H, Gardener S, Ghetti B, Goate A, Goldberg S, Goldman J, Gonzalez A, Gr\u00e4ber-Sultan S, Graff-Radford N, Graham M, Gray J, Gremminger E, Grilo M, Groves A, H\u00e4sler L, Hellm C, Herries E, Hoechst-Swisher L, Hofmann A, Holtzman D, Hornbeck R, Igor Y, Ihara R, Ikeuchi T, Ikonomovic S, Ishii K, Jack C, Jerome G, Johnson E, K\u00e4ser S, Kasuga K, Keefe S, Klunk W (Bill), Koeppe R, Koudelis D, Kuder-Buletta E, Laske C, Levey A, Lopez O, Marsh J, Martinez R, Martins R, Mason NS, Masters C, Mawuenyega K, McCullough A, Mejia A, MountzMD J, Mummery C, Nadkarni N, Nagamatsu A, Neimeyer K, Niimi Y, Noble J, Norton J, O\u2019Connor A, Oberm\u00fcller U, Patira R, Perrin R, Ping L, Preische O, Renton A, Ringman J, Salloway S, Schofield P, Senda M, Seyfried N, Shady K, Shimada H, Sigurdson W, Smith J, Smith L, Snitz B, Sohrabi H, Stephens S, Taddei K, Thompson S, Wang P, Wang Q, Weamer E, Xu J, Xu X, Dominantly Inherited Alzheimer Network (2022) Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol 21(4):329\u2013341. https:\/\/doi.org\/10.1016\/S1474-4422(22)00027-8","journal-title":"Lancet Neurol"},{"issue":"9","key":"13564_CR26","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1523\/JNEUROSCI.1184-19.2019","volume":"40","author":"TW Schmitz","year":"2020","unstructured":"Schmitz TW, Soreq H, Poirier J, Spreng RN (2020) Longitudinal basal forebrain degeneration interacts with TREM2\/C3 biomarkers of inflammation in presymptomatic Alzheimer\u2019s Disease. J Neurosci 40(9):1931\u20131942. https:\/\/doi.org\/10.1523\/JNEUROSCI.1184-19.2019","journal-title":"J Neurosci"},{"key":"13564_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-6209-404-8_14","volume-title":"Handbook of quantitative methods for educational research","author":"MW Gallagher","year":"2013","unstructured":"Gallagher MW, Brown TA (2013) Introduction to confirmatory factor analysis and structural equation modeling. In: Teo T (ed) Handbook of quantitative methods for educational research. Sense Publishers, Rotterdam. https:\/\/doi.org\/10.1007\/978-94-6209-404-8_14"},{"issue":"1","key":"13564_CR28","doi-asserted-by":"publisher","first-page":"e12510","DOI":"10.1002\/dad2.12510","volume":"16","author":"SJ Teipel","year":"2024","unstructured":"Teipel SJ, Dyrba M, Kleineidam L, Brosseron F, Levin F, Bruno D, Buerger K, Cosma N, Schneider LS, D\u00fczel E, Glanz W, Fliessbach K, Janowitz D, Kilimann I, Laske C, Munk MH, Maier F, Peters O, Pomara N, Perneczky R, DELCODE study group and the Alzheimer\u00b4s Disease Neuroimaging Initiative (2024) Association of latent factors of neuroinflammation with Alzheimer\u2019s disease pathology and longitudinal cognitive decline. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 16(1):e12510. https:\/\/doi.org\/10.1002\/dad2.12510","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"3","key":"13564_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3233\/JAD-215196","volume":"85","author":"SJ Teipel","year":"2022","unstructured":"Teipel SJ, Dyrba M, Ballarini T, Brosseron F, Bruno D, Buerger K, Cosma NC, Dechent P, Dobisch L, D\u00fczel E, Ewers M, Fliessbach K, Haynes JD, Janowitz D, Kilimann I, Laske C, Maier F, Metzger CD, Munk MH, Peters O, Pomara N, Preis L, Priller J, Ram\u00edrez A, Roy N, Scheffler K, Schneider A, Schott BH, Spottke A, Spruth EJ, Wagner M, Wiltfang J, Jessen F, Heneka MT (2022) Association of cholinergic basal forebrain volume and functional connectivity with markers of inflammatory response in the Alzheimer\u2019s Disease Spectrum. J Alzheimers Dis 85(3):1267\u20131282. https:\/\/doi.org\/10.3233\/JAD-215196","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"13564_CR30","doi-asserted-by":"publisher","first-page":"e12556","DOI":"10.1002\/dad2.12556","volume":"16","author":"NM Seidu","year":"2024","unstructured":"Seidu NM, Kern S, Sacuiu S, Sterner TR, Blennow K, Zetterberg H, Lindberg O, Ferreira D, Westman E, Zettergren A, Skoog I (2024) Association of CSF biomarkers with MRI brain changes in Alzheimer\u2019s disease. Alzheimers Dement Diagn Assess Dis Monit 16(1):e12556. https:\/\/doi.org\/10.1002\/dad2.12556","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"13564_CR31","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1038\/ncomms7760","volume":"6","author":"S Ayton","year":"2015","unstructured":"Ayton S, Faux NG, Bush AI, Alzheimer\u2019s Disease Neuroimaging Initiative (2015) Ferritin levels in the cerebrospinal fluid predict Alzheimer\u2019s disease outcomes and are regulated by APOE. Nat Commun 6:6760. https:\/\/doi.org\/10.1038\/ncomms7760","journal-title":"Nat Commun"},{"key":"13564_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.dadm.2016.12.002","volume":"6","author":"JD Gispert","year":"2016","unstructured":"Gispert JD, Mont\u00e9 GC, Su\u00e1rez-Calvet M, Falcon C, Tucholka A, Rojas S, Rami L, S\u00e1nchez-Valle R, Llad\u00f3 A, Kleinberger G, Haass C, Molinuevo JL (2016) The APOE \u03b54 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer\u2019s disease but not those of sTREM2. Alzheimers Dement Diagn Assess Dis Monit 6:50\u201359. https:\/\/doi.org\/10.1016\/j.dadm.2016.12.002","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"1","key":"13564_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13195-017-0314-2","volume":"10","author":"F Jessen","year":"2018","unstructured":"Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT, Janowitz D, Kilimann I, Laske C, Menne F, Nestor P, Peters O, Priller J, Pross V, Ramirez A, Schneider A, D\u00fczel E (2018) Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer\u2019s disease (DELCODE). Alzheimer\u2019s Res Ther 10(1):15. https:\/\/doi.org\/10.1186\/s13195-017-0314-2","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"6","key":"13564_CR34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"Jessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Ch\u00e9telat, G., Dubois, B., Dufouil, C., Ellis, K. A., van der Flier, W. M., Glodzik, L., van Harten, A. C., de Leon, M. J., McHugh, P., Mielke, M. M., Molinuevo, J. L., Mosconi, L., Osorio, R. S., Perrotin, A., Petersen, R. C., \u2026 Subjective Cognitive Decline Initiative (SCD-I) Working Group","year":"2014","unstructured":"Jessen, F., Amariglio, R. E., van Boxtel, M., Breteler, M., Ceccaldi, M., Ch\u00e9telat, G., Dubois, B., Dufouil, C., Ellis, K. A., van der Flier, W. M., Glodzik, L., van Harten, A. C., de Leon, M. J., McHugh, P., Mielke, M. M., Molinuevo, J. L., Mosconi, L., Osorio, R. S., Perrotin, A., Petersen, R. C., \u2026 Subjective Cognitive Decline Initiative (SCD-I) Working Group (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement 10(6):844\u2013852. https:\/\/doi.org\/10.1016\/j.jalz.2014.01.001","journal-title":"Alzheimers Dement"},{"issue":"3","key":"13564_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):270\u2013279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008","journal-title":"Alzheimers Dement"},{"issue":"3","key":"13564_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"issue":"7","key":"13564_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34(7):939\u2013944. https:\/\/doi.org\/10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"key":"13564_CR38","doi-asserted-by":"publisher","first-page":"giae049","DOI":"10.1093\/gigascience\/giae049","volume":"13","author":"C Gaser","year":"2024","unstructured":"Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E, The Alzheimer\u2019s Disease Neuroimaging Initiative (2024) CAT: a computational anatomy toolbox for the analysis of structural MRI data. Gigascience 13:giae049. https:\/\/doi.org\/10.1093\/gigascience\/giae049","journal-title":"Gigascience"},{"issue":"2","key":"13564_CR39","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) FSL. NeuroImage 62(2):782\u2013790. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.09.015","journal-title":"Neuroimage"},{"issue":"10","key":"13564_CR40","doi-asserted-by":"publisher","first-page":"e1301","DOI":"10.1212\/WNL.0000000000010192","volume":"95","author":"SJ Teipel","year":"2020","unstructured":"Teipel SJ, Fritz HC, Grothe MJ, Alzheimer\u2019s Disease Neuroimaging Initiative (2020) Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease. Neurology 95(10):e1301\u2013e1311. https:\/\/doi.org\/10.1212\/WNL.0000000000010192","journal-title":"Neurology"},{"issue":"2","key":"13564_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2019.07.018","volume":"16","author":"F Brosseron","year":"2020","unstructured":"Brosseron F, Kolbe CC, Santarelli F, Carvalho S, Antonell A, Castro-Gomez S, Tacik P, Namasivayam AA, Mangone G, Schneider R, Latz E, W\u00fcllner U, Svenningsson P, S\u00e1nchez-Valle R, Molinuevo JL, Corvol JC, Heneka MT, AETIONOMY study group (2020) Multicenter Alzheimer\u2019s and Parkinson\u2019s disease immune biomarker verification study. Alzheimer\u2019s Dementia 16(2):292\u2013304. https:\/\/doi.org\/10.1016\/j.jalz.2019.07.018","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"1","key":"13564_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-018-0353-3","volume":"10","author":"F Brosseron","year":"2018","unstructured":"Brosseron F, Trasch\u00fctz A, Widmann CN, Kummer MP, Tacik P, Santarelli F, Jessen F, Heneka MT (2018) Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer\u2019s disease. Alzheimers Res Ther 10(1):25. https:\/\/doi.org\/10.1186\/s13195-018-0353-3","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"13564_CR43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2021.12.016","volume":"110","author":"F Brosseron","year":"2022","unstructured":"Brosseron F, Maass A, Kleineidam L, Ravichandran KA, Gonz\u00e1lez PG, McManus RM, Ising C, Santarelli F, Kolbe CC, H\u00e4sler LM, Wolfsgruber S, Marqui\u00e9 M, Boada M, Orellana A, de Rojas I, R\u00f6ske S, Peters O, Cosma NC, Cetindag A, Wang X, DELCODE study group (2022) Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer\u2019s disease. Neuron 110(6):1009-1022.e4. https:\/\/doi.org\/10.1016\/j.neuron.2021.12.016","journal-title":"Neuron"},{"issue":"1","key":"13564_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL (2023) Synaptic degeneration in Alzheimer disease. Nat Rev Neurol 19(1):19\u201338. https:\/\/doi.org\/10.1038\/s41582-022-00749-z","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"13564_CR45","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT (2017) Microglia in Alzheimer\u2019s disease. J Clin Invest 127(9):3240\u20133249. https:\/\/doi.org\/10.1172\/JCI90606","journal-title":"J Clin Invest"},{"issue":"11","key":"13564_CR46","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.3390\/ijms25115803","volume":"25","author":"Z Chen","year":"2024","unstructured":"Chen Z, Balachandran YL, Chong WP, Chan KWY (2024) Roles of cytokines in Alzheimer\u2019s disease. Int J Mol Sci 25(11):5803. https:\/\/doi.org\/10.3390\/ijms25115803","journal-title":"Int J Mol Sci"},{"issue":"24","key":"13564_CR47","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.3390\/ijms222413647","volume":"22","author":"A Shah","year":"2021","unstructured":"Shah A, Kishore U, Shastri A (2021) Complement system in Alzheimer\u2019s disease. Int J Mol Sci 22(24):13647. https:\/\/doi.org\/10.3390\/ijms222413647","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13564_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13195-017-0276-4","volume":"9","author":"D Chiasserini","year":"2017","unstructured":"Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L (2017) Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia. Alzheimers Res Ther 9(1):52. https:\/\/doi.org\/10.1186\/s13195-017-0276-4","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"13564_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B (2016) A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87(5):539\u2013547. https:\/\/doi.org\/10.1212\/WNL.0000000000002923","journal-title":"Neurology"},{"key":"13564_CR50","doi-asserted-by":"publisher","first-page":"964075","DOI":"10.3389\/fcell.2022.964075","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, Jiang X, Ma L, Wei W, Li Z, Chang S, Wen J, Sun J, Li H (2022) Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction. Front Cell Dev Biol 10:964075. https:\/\/doi.org\/10.3389\/fcell.2022.964075","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"13564_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, Cao X, Chen Z, Liu D (2021) The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener 10(1):45. https:\/\/doi.org\/10.1186\/s40035-021-00270-1","journal-title":"Transl Neurodegener"},{"key":"13564_CR52","doi-asserted-by":"publisher","first-page":"102642","DOI":"10.1016\/j.arr.2024.102642","volume":"104","author":"Q Cheng","year":"2025","unstructured":"Cheng Q, Fan Y, Zhang P, Liu H, Han J, Yu Q, Wang X, Wu S, Lu Z (2025) Biomarkers of synaptic degeneration in Alzheimer\u2019s disease. Ageing Res Rev 104:102642. https:\/\/doi.org\/10.1016\/j.arr.2024.102642","journal-title":"Ageing Res Rev"},{"issue":"2","key":"13564_CR53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/brain\/awaa406","volume":"144","author":"M Montero-Crespo","year":"2021","unstructured":"Montero-Crespo M, Dom\u00ednguez-\u00c1lvaro M, Alonso-Nanclares L, DeFelipe J, Blazquez-Llorca L (2021) Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer\u2019s disease. Brain 144(2):553\u2013573. https:\/\/doi.org\/10.1093\/brain\/awaa406","journal-title":"Brain"},{"issue":"4","key":"13564_CR54","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41380-023-02399-z","volume":"29","author":"S Levi","year":"2024","unstructured":"Levi S, Ripamonti M, Moro AS, Cozzi A (2024) Iron imbalance in neurodegeneration. Mol Psychiatry 29(4):1139\u20131152. https:\/\/doi.org\/10.1038\/s41380-023-02399-z","journal-title":"Mol Psychiatry"},{"issue":"3","key":"13564_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/jnnp-2022-330052","volume":"94","author":"S Ayton","year":"2023","unstructured":"Ayton S, Janelidze S, Kalinowski P, Palmqvist S, Belaidi AA, Stomrud E, Roberts A, Roberts B, Hansson O, Bush AI (2023) CSF ferritin in the clinicopathological progression of Alzheimer\u2019s disease and associations with APOE and inflammation biomarkers. J Neurol Neurosurg Psychiatry 94(3):211\u2013219. https:\/\/doi.org\/10.1136\/jnnp-2022-330052","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"13564_CR56","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/brain\/awaa089","volume":"143","author":"N Spotorno","year":"2020","unstructured":"Spotorno N, Acosta-Cabronero J, Stomrud E, Lampinen B, Strandberg OT, van Westen D, Hansson O (2020) Relationship between cortical iron and tau aggregation in Alzheimer\u2019s disease. Brain 143(5):1341\u20131349. https:\/\/doi.org\/10.1093\/brain\/awaa089","journal-title":"Brain"},{"key":"13564_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.nbd.2018.12.010","volume":"124","author":"I Diouf","year":"2019","unstructured":"Diouf I, Fazlollahi A, Bush AI, Ayton S, Alzheimer\u2019s disease Neuroimaging Initiative (2019) Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying \u03b2-amyloid pathology. Neurobiol Dis 124:335\u2013339. https:\/\/doi.org\/10.1016\/j.nbd.2018.12.010","journal-title":"Neurobiol Dis"},{"key":"13564_CR58","doi-asserted-by":"publisher","first-page":"888989","DOI":"10.3389\/fnagi.2022.888989","volume":"14","author":"HZ Long","year":"2022","unstructured":"Long HZ, Zhou ZW, Cheng Y, Luo HY, Li FJ, Xu SG, Gao LC (2022) The role of microglia in Alzheimer\u2019s disease from the perspective of immune inflammation and iron metabolism. Front Aging Neurosci 14:888989. https:\/\/doi.org\/10.3389\/fnagi.2022.888989","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"13564_CR59","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/glia.20678","volume":"56","author":"KO Lopes","year":"2008","unstructured":"Lopes KO, Sparks DL, Streit WJ (2008) Microglial dystrophy in the aged and Alzheimer\u2019s disease brain is associated with ferritin immunoreactivity. Glia 56(10):1048\u20131060. https:\/\/doi.org\/10.1002\/glia.20678","journal-title":"Glia"},{"issue":"1","key":"13564_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40478-021-01126-5","volume":"9","author":"B Kenkhuis","year":"2021","unstructured":"Kenkhuis B, Somarakis A, de Haan L, Dzyubachyk O, IJsselsteijn ME, de Miranda NFCC, Lelieveldt BPF, Dijkstra J, van Roon-Mom WMC, H\u00f6llt T, van der Weerd L (2021) Iron loading is a prominent feature of activated microglia in Alzheimer\u2019s disease patients. Acta Neuropathol Commun 9(1):27. https:\/\/doi.org\/10.1186\/s40478-021-01126-5","journal-title":"Acta Neuropathol Commun"},{"key":"13564_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnmol.2015.00018","volume":"8","author":"F Codazzi","year":"2015","unstructured":"Codazzi F, Pelizzoni I, Zacchetti D, Grohovaz F (2015) Iron entry in neurons and astrocytes: a link with synaptic activity. Front Mol Neurosci 8:18. https:\/\/doi.org\/10.3389\/fnmol.2015.00018","journal-title":"Front Mol Neurosci"},{"key":"13564_CR62","doi-asserted-by":"publisher","first-page":"961842","DOI":"10.3389\/fneur.2022.961842","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi X, Zhong X, Zhou H, Zhou N, Hu Y, Ning Y, Alzheimer\u2019s Disease Neuroimaging Initiative (2022) The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer\u2019s continuum. Front Neurol 13:961842. https:\/\/doi.org\/10.3389\/fneur.2022.961842","journal-title":"Front Neurol"},{"issue":"11","key":"13564_CR63","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1038\/s41380-022-01716-2","volume":"27","author":"JP Ferrari-Souza","year":"2022","unstructured":"Ferrari-Souza JP, Ferreira PCL, Bellaver B, Tissot C, Wang YT, Leffa DT, Brum WS, Benedet AL, Ashton NJ, De Bastiani MA, Rocha A, Therriault J, Lussier FZ, Chamoun M, Servaes S, Bezgin G, Kang MS, Stevenson J, Rahmouni N, Pallen V, Pascoal TA (2022) Astrocyte biomarker signatures of amyloid-\u03b2 and tau pathologies in Alzheimer\u2019s disease. Mol Psychiatr 27(11):4781\u20134789. https:\/\/doi.org\/10.1038\/s41380-022-01716-2","journal-title":"Mol Psychiatr"},{"issue":"1","key":"13564_CR64","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/alz.13450","volume":"20","author":"W Pelkmans","year":"2024","unstructured":"Pelkmans W, Shekari M, Brugulat-Serrat A, S\u00e1nchez-Benavides G, Minguill\u00f3n C, Fauria K, Molinuevo JL, Grau-Rivera O, Gonz\u00e1lez Escalante A, Kollmorgen G, Carboni M, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M, Gispert JD, ALFA study (2024) Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer\u2019s disease progression. Alzheimers Dement 20(1):483\u2013493. https:\/\/doi.org\/10.1002\/alz.13450","journal-title":"Alzheimers Dement"},{"key":"13564_CR65","doi-asserted-by":"publisher","first-page":"1630022","DOI":"10.3389\/fnagi.2025.1630022","volume":"17","author":"YY Wang","year":"2025","unstructured":"Wang YY, Zhang M, Chen SJ, Miao W, Wang ZX, Zhou YJ, Yu SQ, Sun ZW, Zhou X, Yu XF, Zhu XQ (2025) Neuroinflammation-mediated YKL-40 correlates with tau pathology and predicts longitudinal cognitive impairment and brain atrophy in Alzheimer\u2019s disease, with hypertensive dependency. Front Aging Neurosci 17:1630022. https:\/\/doi.org\/10.3389\/fnagi.2025.1630022","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"13564_CR66","doi-asserted-by":"publisher","first-page":"e70299","DOI":"10.1002\/mco2.70299","volume":"6","author":"M Huang","year":"2025","unstructured":"Huang M, Long A, Hao L, Shi Z, Zhang M (2025) Astrocyte in neurological disease: pathogenesis and therapy. MedComm 6(8):e70299. https:\/\/doi.org\/10.1002\/mco2.70299","journal-title":"MedComm"},{"issue":"1","key":"13564_CR67","doi-asserted-by":"publisher","first-page":"100013","DOI":"10.1016\/j.tjpad.2024.100013","volume":"12","author":"Z Valiukas","year":"2025","unstructured":"Valiukas Z, Tangalakis K, Apostolopoulos V, Feehan J (2025) Microglial activation states and their implications for Alzheimer\u2019s disease. J Prev Alzheimers Dis 12(1):100013. https:\/\/doi.org\/10.1016\/j.tjpad.2024.100013","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"13564_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-020-00374-8","volume":"15","author":"LZ Ma","year":"2020","unstructured":"Ma LZ, Tan L, Bi YL, Shen XN, Xu W, Ma YH, Li HQ, Dong Q, Yu JT (2020) Dynamic changes of CSF sTREM2 in preclinical Alzheimer\u2019s disease: the CABLE study. Mol Neurodegener 15(1):25. https:\/\/doi.org\/10.1186\/s13024-020-00374-8","journal-title":"Mol Neurodegener"},{"issue":"1","key":"13564_CR69","doi-asserted-by":"publisher","first-page":"15318","DOI":"10.1038\/s41598-024-66211-w","volume":"14","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Seyedmirzaei H, Karami S (2024) Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer\u2019s disease: a longitudinal study. Sci Rep 14(1):15318. https:\/\/doi.org\/10.1038\/s41598-024-66211-w","journal-title":"Sci Rep"},{"issue":"3","key":"13564_CR70","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","volume":"83","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D (2018) High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol 83(3):544\u2013552. https:\/\/doi.org\/10.1002\/ana.25172","journal-title":"Ann Neurol"},{"key":"13564_CR71","doi-asserted-by":"publisher","first-page":"105761","DOI":"10.1016\/j.neuint.2024.105761","volume":"177","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK (2024) Advances in Alzheimer\u2019s disease: a multifaceted review of potential therapies and diagnostic techniques for early detection. Neurochem Int 177:105761. https:\/\/doi.org\/10.1016\/j.neuint.2024.105761","journal-title":"Neurochem Int"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13564-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:03:24Z","timestamp":1773709404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13564-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13564"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13564-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.B. has travel support by Lilly Germany and Novo Nordisk, as well as speaker honoraria by Eisai GmbH Germany and Lilly Germany. S.T. served on advisory boards of Lilly, Eisai, Biogen, and GE, and was a member of the independent data safety and monitoring board of the study ENVISION (Biogen).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study protocol was approved by the local institutional review boards and ethics committees of all participating sites and is conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent prior to participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"46"}}